Stock AnalizIntuitive Surgical Inc. ISRG
Industrial Specialties · IPO 2000 · data as of November 13, 2026
Intuitive Surgical Inc. (ISRG) is a healthcare company listed in the US with a market value of about $153.8B. In the twelve months to September 30, 2026 it had revenue of $11.6B and net income of $3.0B, a net margin of 25.5%.
Its overall Stock Analiz score is 3.2 out of 5 (average). The strongest part is future growth (5/5); the weakest is value (0/5).
Key numbers: a P/E of 53.7, a price to free cash flow of 42.7, 5-year revenue growth of 18% a year, a 5-year average ROIC of 13%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 60% below the current price.
Score: 3.2 / 5
Checks passed
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
- 3-year free cash flow growth above 10% a year
- Strong R&D investment or growth above 20%
- 5-year EPS growth above 10% a year
- 5-year revenue growth above 8% a year
- 5-year average ROIC above 12%
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Pays a dividend
- Share count down over 3 years (buybacks)
- Dividend 3 years in a row
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $11.6B | $10.1B | $8.4B | $7.1B | $6.2B | $5.7B | $4.4B | $4.5B | $3.7B | $3.1B | $2.7B |
| Net income | $3.0B | $2.9B | $2.3B | $1.8B | $1.3B | $1.7B | $1.1B | $1.4B | $1.1B | $671M | $738M |
| Free cash flow | $3.6B | $2.5B | $1.3B | $750M | $958M | $1.7B | $1.1B | $1.2B | $982M | $953M | $1.0B |
| EPS (diluted) | $8.26 | $7.87 | $6.42 | $5.03 | $3.65 | $4.66 | $2.94 | $3.85 | $3.16 | $1.92 | $2.09 |
| Net margin | 25.5% | 28.4% | 27.8% | 25.2% | 21.2% | 29.8% | 24.3% | 30.8% | 30.3% | 21.4% | 27.3% |
| ROIC | — | 14.2% | 12.4% | 12.2% | 11.8% | 13.9% | 9.5% | 15.2% | 15.8% | 13.5% | 12.3% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
What analysts expect
The average 12-month price target from 30 analysts is $486.57, 10% above the current price; targets range from $324.00 to $685.00; the consensus rating is “Buy”; expected EPS is $11.25 for the fiscal year ending December 31, 2026.
Frequently asked questions
What is Intuitive Surgical’s P/E ratio?
About 53.7, based on the last twelve months of diluted earnings per share (forward P/E about 36.9).
Is Intuitive Surgical stock undervalued?
Our DCF model with moderate assumptions puts its intrinsic value about 60% below the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.
Does Intuitive Surgical pay a dividend?
Not currently.
Is Intuitive Surgical a good stock to buy?
We do not give buy or sell advice. Intuitive Surgical scores 3.2 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.